Literature DB >> 21366421

Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.

Roberta Olmo Pinheiro1, Jorgenilce de Souza Salles, Euzenir Nunes Sarno, Elizabeth Pereira Sampaio.   

Abstract

Leprosy, also known as Hansen's disease, is a chronic infectious disease caused by Mycobacterium leprae in which susceptibility to the mycobacteria and its clinical manifestations are attributed to the host immune response. Even though leprosy prevalence has decreased dramatically, the high number of new cases indicates active transmission. Owing to its singular features, M. leprae infection is an attractive model for investigating the regulation of human immune responses to pathogen-induced disease. Leprosy is one of the most common causes of nontraumatic peripheral neuropathy worldwide. The proportion of patients with disabilities is affected by the type of leprosy and delay in diagnosis. This article briefly reviews the clinical features as well as the immunopathological mechanisms related to the establishment of the different polar forms of leprosy, the mechanisms related to M. leprae-host cell interactions and prophylaxis and diagnosis of this complex disease. Host genetic factors are summarized and the impact of the development of interventions that prevent, reverse or limit leprosy-related nerve impairments are discussed.

Entities:  

Mesh:

Year:  2011        PMID: 21366421      PMCID: PMC3123826          DOI: 10.2217/fmb.10.173

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  151 in total

1.  Immunological responsiveness to M. leprae and BCG antigens in 98 leprosy patients and their household contacts.

Authors:  E N Sarno; M Espinosa; E P Sampaio; L M Vieira; A A Figueiredo; C F Miranda; D Esquenazi; J L Salgado; N Nogueira
Journal:  Braz J Med Biol Res       Date:  1988       Impact factor: 2.590

2.  Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy.

Authors:  Rosane B Oliveira; Maria T Ochoa; Peter A Sieling; Thomas H Rea; Anura Rambukkana; Euzenir N Sarno; Robert L Modlin
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

Review 3.  The mycobacteria: an introduction to nomenclature and pathogenesis.

Authors:  N Rastogi; E Legrand; C Sola
Journal:  Rev Sci Tech       Date:  2001-04       Impact factor: 1.181

4.  Dexamethasone synergizes with lenalidomide to inhibit multiple myeloma tumor growth, but reduces lenalidomide-induced immunomodulation of T and NK cell function.

Authors:  A K Gandhi; J Kang; L Capone; A Parton; L Wu; L H Zhang; D Mendy; A Lopez-Girona; T Tran; L Sapinoso; W Fang; S Xu; G Hampton; J B Bartlett; P Schafer
Journal:  Curr Cancer Drug Targets       Date:  2010-03       Impact factor: 3.428

5.  Divergence of macrophage phagocytic and antimicrobial programs in leprosy.

Authors:  Dennis Montoya; Daniel Cruz; Rosane M B Teles; Delphine J Lee; Maria Teresa Ochoa; Stephan R Krutzik; Rene Chun; Mirjam Schenk; Xiaoran Zhang; Benjamin G Ferguson; Anne E Burdick; Euzenir N Sarno; Thomas H Rea; Martin Hewison; John S Adams; Genhong Cheng; Robert L Modlin
Journal:  Cell Host Microbe       Date:  2009-10-22       Impact factor: 21.023

6.  Use of anti-PGL-1 antibodies to monitor therapy regimes in leprosy patients.

Authors:  E M R Zenha; M A N Ferreira; N T Foss
Journal:  Braz J Med Biol Res       Date:  2009-10       Impact factor: 2.590

7.  CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity.

Authors:  P A Sieling; D Jullien; M Dahlem; T F Tedder; T H Rea; R L Modlin; S A Porcelli
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

8.  Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial.

Authors:  F Johannes Moet; David Pahan; Linda Oskam; Jan H Richardus
Journal:  BMJ       Date:  2008-03-10

9.  The cellular content of dermal leprous granulomas: an immuno-histological approach.

Authors:  D Wallach; B Flageul; M A Bach; F Cottenot
Journal:  Int J Lepr Other Mycobact Dis       Date:  1984-09

10.  BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control.

Authors:  Corinne S C Merle; Sergio S Cunha; Laura C Rodrigues
Journal:  Expert Rev Vaccines       Date:  2010-02       Impact factor: 5.217

View more
  20 in total

1.  Leprosy in a texan.

Authors:  Garrett L Vick; Erica A Tillman; Katherine H Fiala
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-04

2.  Evaluation of 16S rRNA qPCR for detection of Mycobacterium leprae DNA in nasal secretion and skin biopsy samples from multibacillary and paucibacillary leprosy cases.

Authors:  Lívia Érika Carlos Marques; Cristiane Cunha Frota; Josiane da Silva Quetz; Alexandre Havt Bindá; Rosa Maria Salane Mota; Maria Araci de Andrade Pontes; Heitor de Sá Gonçalves; Carl Kendall; Ligia Regina Franco Sansigolo Kerr
Journal:  Pathog Glob Health       Date:  2017-12-26       Impact factor: 2.894

Review 3.  Biomarkers for Detecting Resilience against Mycobacterial Disease in Animals.

Authors:  Kathryn Wright; Karren Plain; Auriol Purdie; Bernadette M Saunders; Kumudika de Silva
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

Review 4.  Autophagy in immunity: implications in etiology of autoimmune/autoinflammatory diseases.

Authors:  Xu-Jie Zhou; Hong Zhang
Journal:  Autophagy       Date:  2012-08-14       Impact factor: 16.016

5.  Leprosy and rheumatoid arthritis: consequence or association?

Authors:  Celia Coelho Henriques; Begoña Lopéz; Tiago Mestre; Bruno Grima; António Panarra; Nuno Riso
Journal:  BMJ Case Rep       Date:  2012-08-13

6.  Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7.

Authors:  David Pulido; Marc Torrent; David Andreu; M Victoria Nogués; Ester Boix
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

7.  Biosynthetic Glycan Labeling.

Authors:  Victoria M Marando; Daria E Kim; Phillip J Calabretta; Matthew B Kraft; Bryan D Bryson; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2021-10-04       Impact factor: 16.383

8.  Immune Checkpoints in Leprosy: Immunotherapy As a Feasible Approach to Control Disease Progression.

Authors:  Hayana Ramos Lima; Thaís Helena Gasparoto; Tatiana Salles de Souza Malaspina; Vinícius Rizzo Marques; Marina Jurado Vicente; Elaine Camarinha Marcos; Fabiana Corvolo Souza; Maria Renata Sales Nogueira; Jaison Antônio Barreto; Gustavo Pompermaier Garlet; João Santana da Silva; Vânia Nieto Brito-de-Souza; Ana Paula Campanelli
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

9.  Leprosy: an overview of pathophysiology.

Authors:  Ramesh Marne Bhat; Chaitra Prakash
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-09-04

10.  Hansen's disease with McCune-Albright syndrome.

Authors:  Kvs Hari Kumar; P Dhull; Ys Bisht
Journal:  J Glob Infect Dis       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.